Return to Current Article

Kythera Newsroom

Kythera Biopharmaceuticals Appoints Industry Veteran as Vice President, Global Clinical Operations

April 27, 2010

Pierre J.G. Corin, Ms, Joins Kythera

LOS ANGELES, April 27, 2010 – KYTHERA Biopharmaceuticals, Inc. ("KYTHERA") announced today the appointment of Pierre J.G. Corin, MS, as Vice President, Global Clinical Operations.

Pierre brings more than 20 years of experience in clinical operations and management of large international trials, including specific expertise in aesthetic medicine. Pierre joins KYTHERA from Allergan Medical where he was the Director of Clinical Development and was responsible for the Silicone Breast Implant Follow-Up Study (BIFS).  The BIFS study is the largest multinational post-approval study of its kind.

Prior to Allergan Medical, Pierre held senior positions at several multinational Contract Research Organizations (CROs) including PPD, Covance, ClinTrials and Innovex.

“Pierre joins KYTHERA at a critical time to lead clinical operations as we move toward global registrational trials,” said Patricia Walker, MD, PhD, KYTHERA's Chief Medical Officer. “We are fortunate to have someone with such expertise in managing large scale, multinational trials. I am confident he will add immediate value in planning and guiding our efforts.”

Corin holds an MS from University of Liege (Belgium).